Exhibit 99.1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, each of the persons named below agrees to the joint filing of a Statement on Schedule 13G (including amendments thereto) with respect to the shares of Common Stock of  XOMA Corporation, a Delaware corporation, and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.

 

This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute one agreement.

 

In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of August 19, 2020.

 

 

 

NOVARTIS PHARMA AG

 

 

 

 

 

 

 

By:

/s/ Lukas Foertsch

 

 

Name: Lukas Foertsch

 

 

Title: Authorized Signatory

 

 

 

 

 

 

 

By:

/s/ Stefan Thommen

 

 

Name: Stefan Thommen

 

 

Title: Authorized Signatory

 

 

 

 

 

 

 

NOVARTIS AG

 

 

 

 

 

 

 

By:

/s/ Christian Rehm

 

 

Name: Christian Rehm

 

 

Title: Authorized Signatory

 

 

 

 

 

 

 

By:

/s/ Felix Eichhorn

 

 

Name: Felix Eichhorn

 

 

Title: Authorized Signatory